Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement

Journal of the National Cancer Institute

Volumn 99, Issue 13, 2007, Pages 1044-1049

  Cronin Fenton, Deirdre P ^a,b   Ries, Lynn A ^a   Clegg, Limin X ^c   Edwards, Brenda K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CONFIDENCE INTERVAL; EPIDEMIOLOGICAL DATA; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; MICROMETASTASIS; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UNITED STATES; BREAST TUMOR; CANCER REGISTRY; FEMALE; INCIDENCE; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED;

BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; REGRESSION ANALYSIS; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 34447248537     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm026     Document Type: Article

References (50)

1. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88: 1571-9.
2. Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control 1999;10:333-7.
3. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J Clin 1993;43:27-41.
4. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003;53: 342-55.
5. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
6. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-9.
7. Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen 2002;9:120-4.
8. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
9. Nieweg OE, Estourgie SH. What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004;11 Suppl:169S-73S.
10. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453-63;discussion 463-5.
11. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
12. de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. Stage migration in breast cancer: Surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node. Eur J Surg Oncol 2003;29: 216-20.
13. National Institutes of Health. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
14. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, et al. National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
15. Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J, et al. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection - a description of the trial. Ann Surg Oncol 2004; 11 Suppl:208S-10S.
16. Hsueh EC, Giuliano AE. Sentinel lymph node technique for staging of breast cancer. Oncologist 1998;3:165-70.
17. Singletary SE, Connolly JL. Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006;56:37-47;quiz 50-1.
18. National Comprehensive Cancer Network - Breast Cancer. 2007. Available at: http://www.nccn.org. [Last accessed: June 13, 2007.]
19. Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast;2001 Apr 19-22;Philadelphia PA. Cancer 2002;94:2542-51.
20. Giuliano A. Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 2001;8 Suppl:52S-5S.
21. Maggard MA, Lane KE, O'Connell JB, Nanyakkara DD, Ko CY. Beyond the clinical trials: How often is sentinel lymph node dissection performed for breast cancer? Ann Surg Oncol 2005;12:41-7.
22. Rampaul RS, Miremadi A, Pinder SE, Lee A, Ellis IO. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 2001;3: 113-6.
23. White RL Jr, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004;70:420-4.
24. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173: 44-6.
25. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia PA: Lippincott Williams and Wilkins Publishers; 1998.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
27. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting elay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-45.
28. Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 2003;95:1514-21.
29. Noguchi M, Tsugawa K, Bando E, Kawahara F, Miwa K, Yokoyama K, et al. Sentinel lymphadenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat 1999;53: 97-104.
30. Weaver D. Sentinel lymph nodes and breast carcinoma. Which micrometastases are clinically significant? Am J Surg Pathol 2003;27: 842-5.
31. Noguchi M. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat 2004;84: 261-71.
32. Silberman AW, McVay C, Cohen JS, Altura JF, Brackert S, Sarna GP, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: Implications for patients with breast cancer. Ann Surg 2004;240:1-6.
33. Pendas S, Jakub J, Giuliano R, Gardner M, Swor GB, Reintgen DS. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control 2004;11:231-5.
34. Dubernard G, Sideris L, Delaloge S, Marsiglia H, Rochard F, Travagli JP, et al. Quality of life after sentinel lymph node biopsy in early breast cancer. Eur J Surg Oncol 2004;30:728-34.
35. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel nodenegative breast cancer. J Clin Oncol 2000;18: 2553-9.
36. Leidenius M, Krogerus L, Tukiainen E, von Smitten K. Accuracy of axillary staging using sentinel node biopsy or diagnostic axillary lymph node dissection - a case-control study. APMIS. 2005;112:264-70.
37. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21: 28-34.
38. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
39. Cody HS 3rd, Borgen PI, Tan LK. Redefining prognosis in node-negative breast cancer: Can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy? Ann Surg Oncol 2004;11 Suppl:227S-30S.
40. Weaver DL, Krag DN, Manna EA, Ashikaga T, Waters BL, Harlow SP, et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study. Cancer 2006;107:661-7.
41. Aihara T, Munakata S, Morino H, Takatsuka Y. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 2004;11:747-50.
42. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
43. Pappo I, Meirshon I, Karni T, Siegelmann-Danielli N, Stahl-Kent V, Sandbank J, et al. The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Ann Surg Oncol 2003;11:52-8.
44. Gapstur S, Morrow M, Sellers TA. Hormone replacement therapy and the risk of breast cancer with a favorable histology. JAMA 1999;281:2091-7.
45. Cserni G. Surgical pathological staging of breast cancer by sentinel lymph node biopsy with special emphasis on the histological work-up of axillary sentinel lymph nodes. Breast Cancer 2004;11:242-9.
46. Imoto S, Wada N, Murakami K, Hasebe T, Ochiai A, Ebihara S. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Jpn J Clin Oncol 2004;34:452-6.
47. de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. Stage migration in breast cancer: Surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node. Eur J Surg Oncol 2003;29:216-20.
48. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC Cancer Staging Manual, 5th Edition. Philadelphia PA: Lippincott Williams and Wilkins Publishers;1998.
49. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J Clin 1993;43:27-41.
50. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53:342-55.